Watch this educational video to learn more about HIV bnAbs, sequential immunization, and IAVI’s exciting new approach to HIV vaccine design.
Broadly neutralizing antibodies, bnAbs for short, have the potential to neutralize or prevent infection with, many different HIV strains. IAVI’s goal is to design a series of sequential vaccine candidates that will prepare B cells to produce bnAbs before a person is exposed to HIV. These bnAbs could then protect the person from acquiring HIV if they were exposed to the virus in the future.
We are eager to continue our work developing a safe, effective HIV vaccine, which the world needs.
Originally published here
originally published at Health News -